SCHEDULE 13G: Dr. Raza Bokhari and RBx Capital Disclose Significant Beneficial Ownership in Medicus Pharma Ltd.
Beneficial Ownership Report
Dr. Raza Bokhari and RBx Capital, LP have reported beneficial ownership of 8.9% and 6.7% respectively, of Medicus Pharma Ltd.'s common shares as of December 31, 2024.
Summary
- Dr. Raza Bokhari and RBx Capital, LP jointly filed a Schedule 13G to report their beneficial ownership in Medicus Pharma Ltd.
- As of December 31, 2024, Dr. Raza Bokhari beneficially owns an aggregate of 1,055,673 common shares of Medicus Pharma Ltd., representing 8.9% of the class.
- This beneficial ownership for Dr. Bokhari includes 262,500 common shares underlying stock options that are currently exercisable or will become exercisable within 60 days.
- Additionally, Dr. Bokhari's beneficial ownership includes 793,173 common shares held by RBx Capital, LP, an entity he controls.
- RBx Capital, LP separately reported beneficial ownership of 793,173 common shares, which constitutes 6.7% of Medicus Pharma Ltd.'s common shares.
- The reported percentages are calculated based on 11,816,721 common shares of Medicus Pharma Ltd. reported outstanding as of November 22, 2024.
Sentiment
Score: 5
Explanation: Neutral, as this is a standard beneficial ownership disclosure filing without specific positive or negative operational news or forward-looking statements.
Positives
- Dr. Raza Bokhari, a key individual, holds a significant beneficial ownership stake of 8.9% in Medicus Pharma Ltd., indicating strong alignment with shareholder interests and potential long-term commitment.
Related Party Transactions
- Dr. Raza Bokhari controls RBx Capital, LP, which holds 793,173 common shares of Medicus Pharma Ltd. Dr. Bokhari disclaims beneficial ownership of these shares except to the extent of his direct ownership.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, which can influence investor confidence and understanding of the company's ownership structure.
Key Dates
| Date | Description |
|---|---|
| 2024-11-22 | Date as of which Medicus Pharma Ltd. reported 11,816,721 common shares outstanding, used for percentage calculations. |
| 2024-12-31 | Date of the event requiring the filing of this Schedule 13G, representing the snapshot of beneficial ownership. |
| 2025-02-10 | Date of signature for the Schedule 13G filing by Dr. Raza Bokhari and RBx Capital, LP. |
Keywords
Medicus Pharma Ltd., Schedule 13G, Beneficial Ownership, Raza Bokhari, RBx Capital, Common Shares, SEC Filing, Shareholder Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.